Saneca Pharmaceuticals, a.s. has acquired Suir Pharma Ireland
June 2015 — Saneca Pharmaceuticals, a.s. (Saneca) has acquired Suir Pharma Ireland from mutares AG, an industrial holding company. Financial details have not been disclosed.
Saneca is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns a portfolio of cosmetic and generic products.
Suir Pharma Ireland is an independent contract manufacturing company working with many established pharmaceutical companies worldwide. Formerly a Stada AG manufacturing site, Suir Pharma Ireland is well known as an established manufacturer of generic medicines for more than 40 years with the highest quality standards. The company supplies various markets in Europe and the USA.
mutares AG is an industrial holding company that focuses on the acquisition of companies currently finding themselves in a special situation, such as owner or management succession, strategic repositioning and re-funding.
Our role in the transaction
Oaklins' team in Slovakia advised the buyer in this transaction.
Talk to the deal team
Related deals
Capvis has sold hessnatur to Wourth Group
Hess Natur-Textilien GmbH & Co. KG has become part of the international Wourth Group. With the change of ownership from Capvis to Wourth Group, hessnatur is entering its next phase of development. The transaction reflects the company’s successful strategic and business development in recent years, and creates a strong foundation for the future.
Learn moreNymann Kloak- & Miljøservice has been acquired by Serwent Group
Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn more